<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0010535'>Sleep apnea</z:hpo> is frequently observed in patients with <z:hpo ids='HP_0001635'>heart failure</z:hpo> (HF) </plain></SENT>
<SENT sid="1" pm="."><plain>In general, <z:hpo ids='HP_0010535'>sleep apnea</z:hpo> consists of two types: obstructive and <z:hpo ids='HP_0010536'>central sleep apnea</z:hpo> (OSA and CSA, respectively) </plain></SENT>
<SENT sid="2" pm="."><plain>OSA results from upper airway collapse, whereas CSA arises from reductions in central respiratory drive </plain></SENT>
<SENT sid="3" pm="."><plain>In patients with OSA, blood pressure is frequently elevated as a result of sympathetic <z:mp ids='MP_0008912'>nervous</z:mp> system overactivation </plain></SENT>
<SENT sid="4" pm="."><plain>The generation of exaggerated negative intrathoracic pressure during obstructive <z:hpo ids='HP_0002104'>apneas</z:hpo> further increases left ventricular (LV) afterload, reduces cardiac output, and may promote the progression of HF </plain></SENT>
<SENT sid="5" pm="."><plain>Intermittent <z:mp ids='MP_0005039'>hypoxia</z:mp> and post-apneic reoxygenation cause vascular endothelial damage and possibly <z:hpo ids='HP_0002621'>atherosclerosis</z:hpo> and consequently <z:hpo ids='HP_0001677'>coronary artery disease</z:hpo> and ischemic <z:hpo ids='HP_0001638'>cardiomyopathy</z:hpo> </plain></SENT>
<SENT sid="6" pm="."><plain>CSA is also characterized by <z:hpo ids='HP_0002104'>apnea</z:hpo>, <z:mp ids='MP_0005039'>hypoxia</z:mp>, and increased sympathetic <z:mp ids='MP_0008912'>nervous</z:mp> activity and, when present in HF, is associated with increased risk of <z:hpo ids='HP_0011420'>death</z:hpo> </plain></SENT>
<SENT sid="7" pm="."><plain>In patients with HF, abolition of coexisting OSA by continuous positive airway pressure (CPAP) improves LV function and may contribute to the improvement of long-term outcomes </plain></SENT>
<SENT sid="8" pm="."><plain>Although treatment options of CSA vary compared with OSA treatment, CPAP and other types of positive airway ventilation improve LV function and may be a promising adjunctive therapy for HF patients with CSA </plain></SENT>
<SENT sid="9" pm="."><plain>Since HF remains one of the major causes of mortality in the industrialized countries, the significance of identifying and managing <z:hpo ids='HP_0010535'>sleep apnea</z:hpo> should be more emphasized to prevent the development or progression of HF </plain></SENT>
</text></document>